These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38419270)

  • 81. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial.
    Ridker PM; MacFadyen JG; Everett BM; Libby P; Thuren T; Glynn RJ;
    Lancet; 2018 Jan; 391(10118):319-328. PubMed ID: 29146124
    [TBL] [Abstract][Full Text] [Related]  

  • 82. High sensitivity C-reactive protein and outcomes following percutaneous coronary intervention in contemporary practice.
    Herrmann J; Lennon RJ; Barsness GW; Sandhu GS; Gulati R; Best PJ; Sorajja P; Bresnahan JF; Mathew V; Bell MR; Prasad A
    Circ Cardiovasc Interv; 2012 Dec; 5(6):783-90. PubMed ID: 23212397
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Association of Physical Activity and Inflammation With All-Cause, Cardiovascular-Related, and Cancer-Related Mortality.
    Lee JY; Ryu S; Cheong E; Sung KC
    Mayo Clin Proc; 2016 Dec; 91(12):1706-1716. PubMed ID: 27776840
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Early elevation of high-sensitivity C-reactive protein as a predictor for cardiovascular disease incidence and all-cause mortality: a landmark analysis.
    Lee HS; Lee JH
    Sci Rep; 2023 Aug; 13(1):14118. PubMed ID: 37644061
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Vitamin C Deficiency, High-Sensitivity C-Reactive Protein, and Cardiac Event-Free Survival in Patients With Heart Failure.
    Song EK; Kang SM
    J Cardiovasc Nurs; 2018; 33(1):6-12. PubMed ID: 27984333
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndrome.
    Gager GM; Biesinger B; Hofer F; Winter MP; Hengstenberg C; Jilma B; Eyileten C; Postula M; Lang IM; Siller-Matula JM
    Vascul Pharmacol; 2020 Dec; 135():106806. PubMed ID: 33035661
    [TBL] [Abstract][Full Text] [Related]  

  • 87. C-reactive protein and all-cause mortality in a large hospital-based cohort.
    Marsik C; Kazemi-Shirazi L; Schickbauer T; Winkler S; Joukhadar C; Wagner OF; Endler G
    Clin Chem; 2008 Feb; 54(2):343-9. PubMed ID: 18156283
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention.
    Chen R; Liu C; Zhou P; Tan Y; Sheng Z; Li J; Zhou J; Chen Y; Song L; Zhao H; Yan H
    Mediators Inflamm; 2020; 2020():9343475. PubMed ID: 32377168
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Long-term risk of BP values above normal for cardiovascular mortality: a 24-year observation of Japanese aged 30 to 92 years.
    Takashima N; Ohkubo T; Miura K; Okamura T; Murakami Y; Fujiyoshi A; Nagasawa SY; Kadota A; Kita Y; Miyagawa N; Hisamatsu T; Hayakawa T; Okayama A; Ueshima H;
    J Hypertens; 2012 Dec; 30(12):2299-306. PubMed ID: 23079682
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Associations between Soluble Receptor for Advanced Glycation End Products (sRAGE) and S100A12 (EN-RAGE) with Mortality in Long-term Hemodialysis Patients.
    Jung ES; Chung W; Kim AJ; Ro H; Chang JH; Lee HH; Jung JY
    J Korean Med Sci; 2017 Jan; 32(1):54-59. PubMed ID: 27914132
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Longitudinal High-Sensitivity C-Reactive Protein and Longer-Term Cardiovascular Outcomes in Optimally-Treated Patients With High-Risk Vascular Disease.
    Dykun I; Clark D; Carlo J; Lincoff AM; Menon V; Nissen SE; Nicholls SJ; Puri R
    Am J Cardiol; 2022 Oct; 181():1-8. PubMed ID: 35970631
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Serum High-Sensitivity C-Reactive Protein Levels and the Development of Atrial Fibrillation in a General Japanese Population　- The Hisayama Study.
    Yoshikawa T; Hata J; Sakata S; Nagata T; Hirakawa Y; Hirooka Y; Tsutsui H; Kitazono T; Ninomiya T
    Circ J; 2021 Jul; 85(8):1365-1372. PubMed ID: 33597325
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Association of decreased variation of R-R interval and elevated serum C-reactive protein level in a general population in Japan.
    Kon H; Nagano M; Tanaka F; Satoh K; Segawa T; Nakamura M
    Int Heart J; 2006 Nov; 47(6):867-76. PubMed ID: 17268121
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Abilities of Pre- and Postoperative High-Sensitivity C-Reactive Protein Levels to Predict 90-Day Mortality After Surgery for Abdominal and Thoracic Cancers.
    Oh TK; Choi Y; Oh AY; Chung SH; Han S; Ryu JH
    Ann Surg Oncol; 2018 Nov; 25(12):3660-3666. PubMed ID: 30178394
    [TBL] [Abstract][Full Text] [Related]  

  • 95. How Dietary Patterns are Related to Inflammaging and Mortality in Community-Dwelling Older Chinese Adults in Hong Kong - A Prospective Analysis.
    Chan RSM; Yu BWM; Leung J; Lee JSW; Auyeung TW; Kwok T; Woo J
    J Nutr Health Aging; 2019; 23(2):181-194. PubMed ID: 30697629
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Adding high-sensitivity C-reactive protein to frailty assessment to predict mortality and cardiovascular events in elderly inpatients with cardiovascular disease.
    Yao SM; Zheng PP; Wan YH; Dong W; Miao GB; Wang H; Yang JF
    Exp Gerontol; 2021 Apr; 146():111235. PubMed ID: 33453322
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The relationship between high-sensitivity C-reactive protein and ApoB, ApoB/ApoA1 ratio in general population of China.
    Xu W; Li R; Zhang S; Gong L; Wang Z; Ren W; Xia C; Li Q
    Endocrine; 2012 Aug; 42(1):132-8. PubMed ID: 22246850
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Combined effects of high sensitivity C-reactive protein and triglyceride-glucose index on risk of cardiovascular disease among middle-aged and older Chinese: Evidence from the China Health and Retirement Longitudinal Study.
    Feng G; Yang M; Xu L; Liu Y; Yu J; Zang Y; Shen S; Zheng X
    Nutr Metab Cardiovasc Dis; 2023 Jun; 33(6):1245-1253. PubMed ID: 37095018
    [TBL] [Abstract][Full Text] [Related]  

  • 99. C-reactive protein and serum creatinine, but not haemoglobin A1c, are independent predictors of coronary heart disease risk in non-diabetic Chinese.
    Salim A; Tai ES; Tan VY; Welsh AH; Liew R; Naidoo N; Wu Y; Yuan JM; Koh WP; van Dam RM
    Eur J Prev Cardiol; 2016 Aug; 23(12):1339-49. PubMed ID: 26780920
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Relationship of Serial High-Sensitivity C-Reactive Protein Changes to Long-term Clinical Outcomes in Stabilised Patients After Myocardial Infarction.
    Lee M; Lee K; Kim DW; Cho JS; Kim TS; Kwon J; Kim CJ; Park CS; Kim HY; Yoo KD; Jeon DS; Chang K; Kim MC; Jeong MH; Ahn Y; Park MW
    Can J Cardiol; 2022 Jan; 38(1):92-101. PubMed ID: 34737035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.